Pharmacokinetic interaction potential assessment of cladrin, a potent bioactive constituent of Butea monosperma, and raloxifene, a prescription anti-osteoporotic by in vitro ADME approach
- Publication date
- 28 November 2022
- Publisher
- CSIR-National Institute of Science Communication and Policy Research (NIScPR)